Safety, pharmacokinetics, and pharmacodynamics of S-(−)-pantoprazole sodium injections after single and multiple intravenous doses in healthy Chinese subjects.

Purpose: The objective of this study was to evaluate the safety, pharmacokinetics, and pharmacodynamics of S-(−)-pantoprazole (PPZ) sodium injections following single and multiple intravenous doses in healthy Chinese subjects.Methods: The dosage groups were set as followed: 20 mg of single and multi...

Descripción completa

Detalles Bibliográficos
Publicado en:European Journal of Clinical Pharmacology Vol. 74; no. 3; pp. 257 - 266
Autores principales: Jiao, Hui-Wen, Sun, Lu-Ning, Li, Yue-Qi, Yu, Lei, Zhang, Hong-Wen, Wang, Mei-Feng, Yu, Li-Yuan, Yuan, Zi-Qing-Yun, Xie, Li-Jun, Chen, Juan, Meng, Ling, Zhang, Xue-Hui, Wang, Yong-Qing
Formato: clinical trial research tables/charts Journal Article
Publicado: Springer Nature Mar2018
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=127943477&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 127943477
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00316970
        NP9
      jtl: European Journal of Clinical Pharmacology
      issn: 00316970
      maglogo: N
    pubinfo:
      dt: Mar2018
      vid: 74
      iid: 3
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        127943477
        127943477
        127943477
        10.1007/s00228-017-2372-6
        127943477
      ppf: 257
      ppct: 9
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Safety, pharmacokinetics, and pharmacodynamics of S-(−)-pantoprazole sodium injections after single and multiple intravenous doses in healthy Chinese subjects.
      aug:
        au:
          Jiao, Hui-Wen
          Sun, Lu-Ning
          Li, Yue-Qi
          Yu, Lei
          Zhang, Hong-Wen
          Wang, Mei-Feng
          Yu, Li-Yuan
          Yuan, Zi-Qing-Yun
          Xie, Li-Jun
          Chen, Juan
          Meng, Ling
          Zhang, Xue-Hui
          Wang, Yong-Qing
        affil: Research Division of Clinical Pharmacology, The First Affiliated Hospital with Nanjing Medical University, 300 Guangzhou Road, 210029, Nanjing, People’s Republic of China
      sug:
        subj:
          Patient Safety
          Pantoprazole Sodium Pharmacokinetics
          Pantoprazole Sodium Pharmacodynamics
          Pantoprazole Sodium Administration and Dosage
          Chinese Persons
          Human
          Clinical Trials
          Administration, Intravenous
          Pantoprazole Sodium Blood
          Hydrogen-Ion Concentration
          Gastric Acid Drug Effects
      ab: Purpose: The objective of this study was to evaluate the safety, pharmacokinetics, and pharmacodynamics of S-(−)-pantoprazole (PPZ) sodium injections following single and multiple intravenous doses in healthy Chinese subjects.Methods: The dosage groups were set as followed: 20 mg of single and multiple intravenous administration of S-(−)-PPZ, 40 mg of single and multiple intravenous administration of S-(−)-PPZ or pantoprazole, and 80 mg of single dosage group of S-(−)-PPZ. Subjects were sampled for pharmacokinetic analysis and were monitored for 24-h intragastric pH prior to and 48-h intragastric pH after administration for the pharmacodynamic study. The pharmacokinetic and pharmacodynamic parameters were compared between S-(−)-PPZ and PPZ. Safety was evaluated on the basis of adverse events, vital signs, laboratory tests, and physical examination.Results: All adverse events were mild and of limited duration. Maximum plasma concentration and area under the concentration-time curve for S-(−)-PPZ were dose proportional over the range of 20–80 mg following a single intravenous administration. Elimination rate constant and half-life observed statistical difference from a single dose to multiple doses in 40 mg of S-(−)-PPZ groups. After administration of a single dose, the mean 24-h intragastric pH value was observed higher in 80-mg group than in 40- and 20-mg groups. Slightly increase of intragastric pH was found after a single dose of 40 mg S-(−)-PPZ than 40 mg PPZ; however, the differences were not statistically significant.Conclusions: Twice daily of 40 mg S-(−)-PPZ sodium injections is effective in achieving satisfying acid inhibition. Compared with plasma R-(+)-PPZ levels, most subjects presented more potent and prolonged suppression of gastric acid of S-(−)-PPZ, while a few subjects showed faster metabolic rate of S-(−)-PPZ in vivo.
      pubtype: Academic Journal
      doctype:
        clinical trial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N